Work

Co-Targeting BET Bromodomain Proteins and Aberrant Signaling in AML

Year: 2020

Type: article

Source: Blood

DOI: 10.1182/blood-2020-142921

Authors: Benjamin J. Huang, Xinyue Wang, Max Harris, Anica Wandler, Eugene Hwang, Michael R. Burgess, Qing Li, Paul Severson, Ben Powell, Edward A. Kolb, Soheil Meshinchi, Barry S Taylor, Gideon Bollag, Kevin M. Shannon

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Bristol-Myers Squibb (United States), University of Michigan, Michigan Medicine, Plexxikon (United States), Alfred I. duPont Hospital for Children, University of Washington, Fred Hutch Cancer Center, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Protein Degradation and Inhibitors

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3097001108

FWCI: 0.07

Cites:

Cited by: 3

Related to: 10